Hengkang Medical Group Co Ltd Cash Flow Conversion Efficiency
Hengkang Medical Group Co Ltd cash flow conversion efficiency. Based on the latest financial reports, Hengkang Medical Group Co Ltd (002219) has a cash flow conversion efficiency ratio of 0.005x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥9.35 Million ≈ $1.37 Million USD) by net assets (CN¥2.02 Billion ≈ $296.06 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Hengkang Medical Group Co Ltd (2004–2024)
Cash flow conversion efficiency of Hengkang Medical Group Co Ltd from 2004 to 2024. This chart illustrates how Hengkang Medical Group Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View 002219 share price today for real-time trading data and today's change.
Hengkang Medical Group Co Ltd Cash Flow Conversion Ratio Explained
Hengkang Medical Group Co Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Hengkang Medical Group Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Hengkang Medical Group Co Ltd ranked by their cash flow conversion efficiency. Also see Hengkang Medical Group Co Ltd (002219) market capitalisation for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Centerspace
NYSE:CSR
|
0.055x |
|
Aavas Financiers Limited
NSE:AAVAS
|
-0.024x |
|
Jinzi Ham Co Ltd
SHE:002515
|
-0.006x |
|
Pick N Pay Stores Ltd
JSE:PIK
|
0.028x |
|
LX International Corp
KO:001120
|
0.074x |
|
Dazzle Fashion Co Ltd
SHG:603587
|
0.031x |
|
Jubilant Ingrevia Limited
NSE:JUBLINGREA
|
0.032x |
|
Orchid Island Capital Inc.
NYSE:ORC
|
0.057x |
Annual Cash Flow Conversion Efficiency for Hengkang Medical Group Co Ltd (2004–2024)
The table below shows the annual cash flow conversion efficiency of Hengkang Medical Group Co Ltd from 2004 to 2024. Review 002219 free cash flow to operating cash ratio to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥2.04 Billion ≈ $298.62 Million |
CN¥438.51 Million ≈ $64.17 Million |
0.215x | +65.01% |
| 2023-12-31 | CN¥2.23 Billion ≈ $326.98 Million |
CN¥290.98 Million ≈ $42.58 Million |
0.130x | -14.23% |
| 2022-12-31 | CN¥1.77 Billion ≈ $258.33 Million |
CN¥268.04 Million ≈ $39.22 Million |
0.152x | -13.16% |
| 2021-12-31 | CN¥1.59 Billion ≈ $232.09 Million |
CN¥277.29 Million ≈ $40.58 Million |
0.175x | -90.28% |
| 2020-12-31 | CN¥157.84 Million ≈ $23.10 Million |
CN¥283.80 Million ≈ $41.53 Million |
1.798x | -32.10% |
| 2019-12-31 | CN¥207.51 Million ≈ $30.37 Million |
CN¥549.51 Million ≈ $80.41 Million |
2.648x | +1348.10% |
| 2018-12-31 | CN¥2.86 Billion ≈ $418.16 Million |
CN¥522.57 Million ≈ $76.47 Million |
0.183x | +488.16% |
| 2017-12-31 | CN¥4.35 Billion ≈ $636.19 Million |
CN¥-204.82 Million ≈ $-29.97 Million |
-0.047x | +71.81% |
| 2016-12-31 | CN¥4.17 Billion ≈ $610.59 Million |
CN¥-697.37 Million ≈ $-102.05 Million |
-0.167x | -390.19% |
| 2015-12-31 | CN¥3.80 Billion ≈ $556.49 Million |
CN¥219.02 Million ≈ $32.05 Million |
0.058x | -68.57% |
| 2014-12-31 | CN¥1.06 Billion ≈ $154.43 Million |
CN¥193.35 Million ≈ $28.29 Million |
0.183x | -5.06% |
| 2013-12-31 | CN¥820.80 Million ≈ $120.11 Million |
CN¥158.40 Million ≈ $23.18 Million |
0.193x | +30.82% |
| 2012-12-31 | CN¥560.65 Million ≈ $82.04 Million |
CN¥82.71 Million ≈ $12.10 Million |
0.148x | -25.75% |
| 2011-12-31 | CN¥477.16 Million ≈ $69.82 Million |
CN¥94.80 Million ≈ $13.87 Million |
0.199x | +27.73% |
| 2010-12-31 | CN¥414.18 Million ≈ $60.61 Million |
CN¥64.43 Million ≈ $9.43 Million |
0.156x | +69.04% |
| 2009-12-31 | CN¥354.57 Million ≈ $51.88 Million |
CN¥32.63 Million ≈ $4.77 Million |
0.092x | +28.34% |
| 2008-12-31 | CN¥311.99 Million ≈ $45.65 Million |
CN¥22.37 Million ≈ $3.27 Million |
0.072x | -67.90% |
| 2007-12-31 | CN¥142.72 Million ≈ $20.88 Million |
CN¥31.88 Million ≈ $4.67 Million |
0.223x | +79.57% |
| 2006-12-31 | CN¥108.93 Million ≈ $15.94 Million |
CN¥13.55 Million ≈ $1.98 Million |
0.124x | -69.47% |
| 2005-12-31 | CN¥89.67 Million ≈ $13.12 Million |
CN¥36.54 Million ≈ $5.35 Million |
0.407x | +38339.94% |
| 2004-12-31 | CN¥72.09 Million ≈ $10.55 Million |
CN¥76.41K ≈ $11.18K |
0.001x | -- |
About Hengkang Medical Group Co Ltd
New Journey Health Technology Group Co.,LTD, together with its subsidiaries, provides medical services and pharmaceuticals products in China and internationally. The company operates regional medical centers to treat aging diseases, such as tumors, cardiovascular, cerebrovascular, and orthopedics. It is also involved in the research, development, production, and sale of medicines comprising Duyiw… Read more